ŞANGHAY, 18 Eylül 2026 /PRNewswire/ -- HUAWEI CONNECT 2026 etkinliğinde Huawei, "Sınırsız İşbirliğiyle Daha Akıllı Bir Geleceği Kucaklamak" başlıklı akıllı işbirliği oturumu sırasında çığır açan, sürükleyici bir telepresence sistemini tanıttı." Şirket ayrıca, yapay zeka destekli toplantı...
RADNOR, Pa., Sept. 18, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by D-Wave Quantum Inc. ("D-Wave") (NASDAQ: QBTS) on behalf of...
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from a discrete choice experiment highlighting preferred healthcare provider (HCP) treatment attributes when selecting a VMAT2 inhibitor for the treatment of TD in older patients (aged ≥55 years). The new findings were presented at Psych Congress, held September 15 – 19, 2026, in New Orleans, LA.
San Diego, California--(Newsfile Corp. - September 18, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Ryde Group Ltd (NYSE American: RYDE) securities between March 6, 2024 and September 11, 2024, inclusive (the "Class Period"). RYDE's claimed "vision is to become a 'Super mobility app' where multiple mobility tools can be accessed and function seamlessly out of a single...
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new real-world data evaluating treatment continuity, healthcare resource utilization (HCRU) and clinical outcomes among adults with schizophrenia and bipolar I disorder (BD-I) treated with UZEDY (risperidone) extended-release injectable suspension. The results demonstrate how UZEDY helps patients with schizophrenia remain on treatment longer while reducing emergency care and healthcare costs compared with other treatment options. The new findings were presented at Psych Congress, held September 15 – 19, 2026, in New Orleans, LA.
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. ("Hyliion" or the "Company") (NYSE American: HYLN) on behalf of investors that purchased or otherwise acquired Hyliion securities between May 12, 2026 and June 23, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hyliion and have suffered losses, you may CLICK HERE to contact us. You may also...
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2026) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announces that, further to the investor rights agreement dated November 3, 2021 (the "Sumitomo IRA") between the Company and Sumitomo Metal Mining Canada Ltd. ("Sumitomo") and the investor rights agreement dated May 28, 2024 (the "Centerra IRA") between the Company and Centerra Gold Inc. ("Centerra"), each of Sumitomo and Centerra have...
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of new olanzapine LAI (TEV-'749) post hoc data from the pivotal SOLARIS Phase 3 trial as well as analyses supporting treatment switch strategies. The SOLARIS data highlighted the acute and long-term durability, efficacy and safety of TEV-'749 as a once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the treatment of schizophrenia in adults. The findings were presented at Psych Congress, held September 15 – 19, 2026, in New Orleans, LA.
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 18, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alibaba Group Holding Limited (NYSE:BABA) between June 26, 2025 and June 24, 2026, both dates inclusive (the "Class Period"), of the important October 5, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Alibaba securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To ..
(PR-inside.com) With special education enrollment at a record 8.2 million and special education teacher shortages in 45 states, knowing the law matters more than ever. BOSTON, MA / ACCESS Newswire / September 18, 2026 / Most parents of children with cerebral palsy (CP) never use the full set of available school rights, according to Cerebral Palsy Guide, which says the gap persists largely because families do not know what they can ask for. Federal law guarantees children with disabilities ages 3 to 21 a free, appropriate public education (FAPE), delivered through the Individualized Education Program (IEP). The IEP is a legally binding plan, ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 18, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of HDFC Bank Limited (NYSE:HDB) between July 17, 2023 to May 26, 2026, inclusive (the "Class Period"), of the important October 13, 2026 lead plaintiff deadline. SO WHAT: If you purchased HDFC Bank securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the HDFC Bank class action, go to https://rosenlegal.com/cases/hdfc-bank-limited/join or call Phillip ..
CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston